Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy
NCT ID: NCT01847612
Last Updated: 2025-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
150 participants
INTERVENTIONAL
2013-07-08
2025-07-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Indocyanine Green Fluorescence in Evaluation of Pancreatic Remnant Perfusion.
NCT06198400
Postoperative Biliary Fistula Prevention After Hepatectomy
NCT01469442
Using Indocyanine Green (ICG) to Outline Biliary Tree During Laparoscopic Cholecystectomy
NCT06629415
Fluorescent Cholangiography in Acute Cholecystitis
NCT06573021
Fluorescence Cholangiography During Cholecystectomy - a RCT
NCT02344654
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
indocyanine green fluorescent cholangiography
use of indocyanine green fluorescent cholangiography in the patients of this arm, an indocyanine green fluorescent cholangiography is performed
indocyanine green fluorescent cholangiography
methylene blue
injection of methylene blue during the surgery
methylene blue
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
indocyanine green fluorescent cholangiography
methylene blue
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* liver resection by laparotomy
* written consent
Exclusion Criteria
* emergency surgery
* allergy to indocyanine green
* allergy to methylene blue
* pregnancy or breastfeeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
jean marc regimbeau, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU amiens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amiens University Hospital
Amiens, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nguyen-Khac E, Lobry C, Chatelain D, Fuks D, Joly JP, Brevet M, Tramier B, Mouly C, Hautefeuille V, Chauffert B, Regimbeau JM. A Reappraisal of Chemotherapy-Induced Liver Injury in Colorectal Liver Metastases before the Era of Antiangiogenics. Int J Hepatol. 2013;2013:314868. doi: 10.1155/2013/314868. Epub 2013 Mar 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-000408-40
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
PI2013_843_0003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.